Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis

Yu, Jun; Hui, Alex Y.; Chu, Eagle S. H.; Cheng, Alfred S. L.; Go, Minnie Y. Y.; Chan, Henry L. Y.; Leung, Wai K.; Cheung, Kin F.; Ching, Arthur K. K.; Chui, Yiu L.; Chan, Ka K.; Sung, Joseph J. Y.
July 2007
Gut;Jul2007, Vol. 56 Issue 7, p991
Academic Journal
Background: It has been proved that cyclo-oxygenase-2 (COX-2) is rapidly induced by inflammatory mediators. However, it is not known whether overexpression of COX-2 in the liver is sufficient to promote activation or secretion of inflammatory factors leading to hepatitis. Aim: To investigate the role forced expression of COX-2 in liver by using inducible COX-2 transgenic (TG) mice. Methods: TG mice that overexpress the human COX-2 gene in the liver using the liver-specific transthyretin promoter and non-TG littermates were derived and fed the normal diet far up to 12 months. Hepatic prostaglandin E2 (PGE2) content was determined using enzyme immunoassay, nuclear factor kappaB (NF-KB) activation by electrophoretic mobilily shift assays, apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labelling and proliferation by Ki-67 immunohistochemistry. Results: COX-2 TG mice exhibited strongly increased COX-2 and PGE2, elevated serum alanine aminotransferase level and histological hepatitis. Hepatic COX-2 expression in the TG mice resulted in activation of NF-κB and inflammatory cytokine cascade, with a marked expression of the proinflammatory cytokines tumour necrosis factor (TNF)-α (9.4-fald), interleukin (IL)-6 (4.4-fold), IL-1β (3.6-fold), and of the anti-inflammatory cytokine IL-10 (4.4-fald) and chemokine macrophage inflammatory protein-2 (3.2-fald). The inflammatory response of the COX-2 TG mice was associated with infiltration macrophages and lymphocytes, increased cell proliferation and high rates of cell apoptosis. Administration of the COX-2 inhibitor celecoxib in TG mice restored liver histology to normal. Conclusion: Enhanced COX-2 expression in hepatocytes is sufficient to induce hepatitis by activating NF-κB, stimulating the secretion of proinflammatory cytokines, recruiting macrophage and altering cell kinetics. Inhibition of COX-2 represents a mechanism-based chemopreventive approach to hepatitis.


Related Articles

  • Effects of Adiponectin Transgenic Expression in Model Mice for NASH. Nakayama, Hitomi; Otabe, Shuichi; Ueno, Takato; Hirota, Naotoshi; Yuan, Xiaohong; Fukutani, Tomoka; Hashinaga, Toshihiko; Wada, Nobuhiko; Nakayama, Satoshi; Yamada, Kentaro // Diabetes;Jun2007 Supplement 1, Vol. 56, pA40 

    Nonalcoholic steatohepatitis (NASH) is one of the life-threatening hepatic diseases associated with insulin resistance. We have previously reported that transgenic mice expressing nuclear sterol regulatory element-binding protein 1c (nSREBP-1c) in adipose tissue, an inherited lipodystrophic...

  • Transgenic mice expressing bacterial phytase as a model for phosphorus pollution control. Golovan, Serguei P.; Hayes, M. Anthony; Phillips, John P.; Forsberg, Cecil W. // Nature Biotechnology;May2001, Vol. 19 Issue 5, p429 

    We have developed transgenic mouse models to determine whether endogenous expression of phytase transgenes in the digestive tract of monogastric animals can increase the bioavailability of dietary phytate, a major but indigestible form of dietary phosphorus. We constructed phytase transgenes...

  • Hepatitis B virus transgenic mouse model of chronic liver disease. Larkin, Jonathan; Clayton, Marcy; Sun, Bill; Perchonock, Claire E.; Morgan, Judith L.; Siracusa, Linda D.; Michaels, Frank H.; Feitelson, Mark A. // Nature Medicine;Aug99, Vol. 5 Issue 8, p907 

    A model for hepatitis B virus-associated chronic liver disease has been made using cloned hepatitis B virus DNA as a transgene in a severe combined immunodeficient host. These mice consistently support virus gene expression and replication. After adoptive transfer of unprimed, syngeneic...

  • Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice. Mimura, Sumie; Mochida, Satoshi; Inao, Mie; Matsui, Atsushi; Nagoshi, Sumiko; Yoshimoto, Takayuki; Fujiwara, Kenji // Journal of Gastroenterology;2004, Vol. 39 Issue 9, p867 

    The article presents a study on the relation of T-helper (Th)1 and Th2 immune imbalance to massive liver necrosis, using transgenic mice. The study established transgenic mice expressing osteopontin exclusively in hepatocytes, using a vector containing human serum amyloid P component promoter....

  • Increased Neuronal Injury in Transgenic Mice with Neuronal Overexpression of Human Cyclooxygenase-2 is reversed by Hypothermia and Rofecoxib Treatment. Zhongmin Xiang; Thomas, Sunil; Pasinetti, Giulio // Current Neurovascular Research;Oct2007, Vol. 4 Issue 4, p274 

    Cyclooxygenase-2 (COX-2) is up-regulated during ischemia. However, the role of COX-2 in neuronal injury is still unclear. In this study we tested whether neuronal overexpression of human COX-2 in a transgenic mouse model potentiates neuronal injury after global ischemic insult. Further, we...

  • Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. Chen, C.-C.; Ko, T.-M.; Ma, H.-I.; Wu, H.-L.; Xiao, X.; Li, J.; Chang, C.-M.; Wu, P.-Y.; Chen, C.-H.; Han, J.-M.; Yu, C.-P.; Jeng, K.-S.; Hu, C.-P.; Tao, M.-H. // Gene Therapy;Jan2007, Vol. 14 Issue 1, p11 

    RNA interference (RNAi) was reported to block hepatitis B virus (HBV) gene expression and replication in vitro and in vivo. However, it remains a technical challenge for RNAi-based therapy to achieve long-term and complete inhibition effects in chronic HBV infection, which presumably requires...

  • Complex roles of cyclo-oxygenase 2 in hepatitis. Hoit, Andrew P.; Adams, David H. // Gut;Jul2007, Vol. 56 Issue 7, p903 

    The article comments on a paper which examines the roles of cyclo-oxygenase 2 (COX2) in hepatitis. The authors stress that this study suggests that COX2 is directly implicated in hepatitis. They mention some findings of the study that warrant further examination. They emphasize that in the...

  • Expression of biologically active human interferon alpha 2b in the milk of transgenic mice. Li, Hui; Liu, Qingyou; Cui, Kuiqing; Liu, Jinfeng; Ren, Yanping; Shi, Deshun // Transgenic Research;Feb2013, Vol. 22 Issue 1, p169 

    Interferon alpha 2b (IFNα-2b) is an important immune regulator widely used in clinic, for the treatment of chronic hepatitis, hairy cell leukemia, chronic myelogenous leukemia and multiple myeloma, etc. The clinically used IFNα-2b is generally produced by E.Coli, which lacks the...

  • Transgenic Expression of Entire Hepatitis B Virus in Mice Induces Hepatocarcinogenesis Independent of Chronic Liver Injury. Bing Na; Zhiming Huang; Qian Wang; Zhongxia Qi; Yongjun Tian; Cheng-Chan Lu; Jingwei Yu; Hanes, Martha A.; Kakar, Sanjay; Huang, Eric J.; Ou, J.-H. James; Limin Liu; Yen, T. S. Benedict // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide, is most commonly caused by chronic hepatitis B virus (HBV) infection. However, whether HBV plays any direct role in carcinogenesis, other than indirectly causing chronic liver injury by inciting the host immune...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics